Correlation Between Ginkgo Bioworks and Adaptive Biotechnologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ginkgo Bioworks and Adaptive Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ginkgo Bioworks and Adaptive Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ginkgo Bioworks Holdings and Adaptive Biotechnologies Corp, you can compare the effects of market volatilities on Ginkgo Bioworks and Adaptive Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ginkgo Bioworks with a short position of Adaptive Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ginkgo Bioworks and Adaptive Biotechnologies.

Diversification Opportunities for Ginkgo Bioworks and Adaptive Biotechnologies

0.07
  Correlation Coefficient

Significant diversification

The 3 months correlation between Ginkgo and Adaptive is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Ginkgo Bioworks Holdings and Adaptive Biotechnologies Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adaptive Biotechnologies and Ginkgo Bioworks is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ginkgo Bioworks Holdings are associated (or correlated) with Adaptive Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adaptive Biotechnologies has no effect on the direction of Ginkgo Bioworks i.e., Ginkgo Bioworks and Adaptive Biotechnologies go up and down completely randomly.

Pair Corralation between Ginkgo Bioworks and Adaptive Biotechnologies

Considering the 90-day investment horizon Ginkgo Bioworks Holdings is expected to under-perform the Adaptive Biotechnologies. In addition to that, Ginkgo Bioworks is 1.37 times more volatile than Adaptive Biotechnologies Corp. It trades about -0.06 of its total potential returns per unit of risk. Adaptive Biotechnologies Corp is currently generating about 0.12 per unit of volatility. If you would invest  611.00  in Adaptive Biotechnologies Corp on December 29, 2024 and sell it today you would earn a total of  211.00  from holding Adaptive Biotechnologies Corp or generate 34.53% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Ginkgo Bioworks Holdings  vs.  Adaptive Biotechnologies Corp

 Performance 
       Timeline  
Ginkgo Bioworks Holdings 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Ginkgo Bioworks Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Adaptive Biotechnologies 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Adaptive Biotechnologies Corp are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively abnormal basic indicators, Adaptive Biotechnologies unveiled solid returns over the last few months and may actually be approaching a breakup point.

Ginkgo Bioworks and Adaptive Biotechnologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ginkgo Bioworks and Adaptive Biotechnologies

The main advantage of trading using opposite Ginkgo Bioworks and Adaptive Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ginkgo Bioworks position performs unexpectedly, Adaptive Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adaptive Biotechnologies will offset losses from the drop in Adaptive Biotechnologies' long position.
The idea behind Ginkgo Bioworks Holdings and Adaptive Biotechnologies Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years